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AbstrAct
Introduction Electronic health records (EHRs) are 
increasingly used to estimate the prevalence of childhood 
asthma. The relation of these estimates to those obtained 
from parent-reported wheezing suggestive of asthma is 
unclear. We hypothesised that parent-reported wheezing 
would be more prevalent than general practitioner (GP)-
recorded asthma diagnoses in preschool-aged children.
Methods 1529 of 1840 (83%) Millennium Cohort Study 
children registered with GPs in the Welsh Secure Anonymised 
Information Linkage databank were linked. Prevalences 
of parent-reported wheezing and GP-recorded asthma 
diagnoses in the previous 12 months were estimated, 
respectively, from parent report at ages 3, 5, 7 and 11 years, 
and from Read codes for asthma diagnoses and prescriptions 
based on GP EHRs over the same time period. Prevalences 
were weighted to account for clustered survey design and 
non-response. Cohen’s kappa statistics were used to assess 
agreement.
results Parent-reported wheezing was more prevalent 
than GP-recorded asthma diagnoses at 3 and 5 years. Both 
diminished with age: by age 11, prevalences of parent-
reported wheezing and GP-recorded asthma diagnosis 
were 12.9% (95% CI 10.6 to 15.4) and 10.9% (8.8 to 13.3), 
respectively (difference: 2% (−0.5 to 4.5)). Other GP-recorded 
respiratory diagnoses accounted for 45.7% (95% CI 37.7 
to 53.9) and 44.8% (33.9 to 56.2) of the excess in parent-
reported wheezing at ages 3 and 5 years, respectively.
conclusion Parent-reported wheezing is more prevalent 
than GP-recorded asthma diagnoses in the preschool 
years, and this difference diminishes in primary school-
aged children. Further research is needed to evaluate the 
implications of these differences for the characterisation of 
longitudinal childhood asthma phenotypes from EHRs.
IntroductIon
There is increasing use of coded informa-
tion from primary care and hospital elec-
tronic health records (EHRs) to estimate the 
frequency, onset, persistence, severity and 
outcomes of long-standing childhood condi-
tions, including childhood asthma.1–7 Asthma 
is the most common long-term childhood 
medical condition in the UK, among the highest 
prevalence in children worldwide,8 with 1 in 11 
children aged under 16 years receiving treat-
ment in the UK. Between-country comparisons 
of asthma prevalence in early childhood, such 
as those reported by the International Study of 
Asthma and Allergies in Childhood (ISAAC) 
and planned by the Global Asthma Network,9 
are based on parent-reported wheezing symp-
toms suggestive of asthma using validated and 
standardised questionnaires within cross-sec-
tional surveys.
More recently, the potential contribution of 
EHRs to our understanding of asthma has been 
highlighted by their use in a comprehensive 
assessment of asthma epidemiology and health 
service use and costs in the UK.10 EHRs offer an 
alternative approach to estimating the burden 
of childhood asthma at a population level 
and changes over time in relation to environ-
mental exposures and interventions. However, 
the relation of epidemiological measures of 
disease frequency based on coded information 
recorded in general practitioner (GP) records 
to parent-reported wheezing suggestive of 
asthma across the early life course is unclear. 
Linking electronic health records within longi-
tudinal studies such as birth cohorts offers 
an opportunity to compare the prevalence of 
parent-reported wheezing with that of asthma 
diagnoses derived from GP records across early 
childhood.
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We compared GP-recorded asthma diagnoses docu-
mented in linked primary care EHRs to parent-re-
ported wheezing over the first 11 years of life in Welsh 
children participating in the Millennium Cohort Study 
(MCS). We hypothesised that parent-reported wheezing 
in the preceding 12 months would be more prevalent 
than GP-recorded asthma diagnoses over the same time 
period, particularly among preschool-aged children, 
and examined the extent to which other respiratory 
diagnoses coded in GP records might account for any 
differences.
Methods
subjects
The MCS is a prospective study of 18 819 British chil-
dren born between 2000 and 2002 whose parents were 
first interviewed when their child was aged 9 months and 
subsequently at ages 3, 5, 7 and 11 years, when informa-
tion was collected on social and health factors related to 
the child and their family. At the age 7 year interview, 
parents of 1840 (94.3%) of 1951 singleton children 
interviewed in Wales gave consent to link information 
collected within MCS to their child’s routine health 
records up to their 14th birthday.
Linked records
Linkage of MCS data to routine primary care EHRs was 
facilitated by the privacy protecting Secure Anonymised 
Information Linkage (SAIL) databank, which currently 
has permission to use anonymised records for research 
from 78% of general practices in Wales. Datasets 
imported into SAIL are anonymised and linked by 
assigning unique Anonymised Linkage Fields to person-
based records.11 Linkage was made to information in 
the Welsh Demographic Service for 1834 (99.7%) of 
the 1840 cohort members, 1529 (83.1%) of whom were 
registered before their 14th birthday with a GP partici-
pating in SAIL: 1501 (98.2%) of children registered with 
these practices had at least one GP event (diagnosis or 
prescription) record. At ages 3, 5, 7 and 11 years, respec-
tively, 129, 101, 102 and 85 children were not registered 
with a GP during the relevant 12-month time period used 
to estimate period prevalence. The parents of 116, 76, 0 
and 226 children did not take part at the age 3, 5, 7 and 
11 year interviews, while across all ages, a total of 17 chil-
dren had missing information on reported wheeze. Thus, 
linked records were available for 1280 (607 girls), 1347 
(645 girls), 1426 (685 girls) and 1211 (573 girls) children 
at ages 3, 5, 7 and 11 years, respectively, and were used 
to estimate prevalences. There were no differences in 
child sex, mean interview age, household income poverty 
(<60% national median income) or maternal history of 
asthma for children with a linked GP record compared 
with those without (data not shown).
Wheezing and asthma diagnoses
We derived, for each child, a binary variable for parent-re-
ported wheezing (yes/no) in the 12 months preceding 
their actual date of MCS interview at ages 3, 5, 7 and 11 
years from parental responses to the ISAAC12 standard-
ised question ‘Has your child had wheezing or whistling 
in the chest in the last 12 months?’
At the MCS interviews held at ages 5, 7 and 11 years, 
parents were asked if their child took any medicines on a 
regular basis (defined as every day for 2 weeks or more) 
that were prescribed by a doctor or hospital. If so, the 
type of medicine was recorded and coded using British 
National Formulary codes. We examined parent-reported 
use of asthma-related drug treatments, including use 
of bronchodilators (British National Formulary (BNF) 
code: 3.1) and corticosteroids (BNF code 3.2).
Asthma diagnoses were derived for each child using 
Read codes employed in the UK Quality and Outcomes 
Framework to identify GP-recorded asthma diagnoses 
and/or relevant prescriptions issued for asthma-related 
medications for children registered with a GP for the 
full year or part of it (see online supplementary file: 
appendix).13 GP-recorded asthma diagnosis (yes/no) was 
assigned to each child for the 12 months preceding their 
actual date of MCS interview at each age as follows: (1) 
diagnostic codes for asthma and/or prescription issued 
for an asthma-related medication (‘GP-recorded asthma 
diagnosis’) or (2) no diagnostic code for asthma or asth-
ma-related prescriptions issued (‘no GP-recorded asthma 
diagnosis’). Read codes for other respiratory illnesses 
(see online supplementary file: appendix) were also 
identified for the same time periods for children with 
parent-reported wheezing and for whom there was no 
GP-recorded asthma diagnosis in that time period.
statistical analyses
Survey and non-response weights at age 7 years were 
calculated to account for clustered sampling and attrition 
due to loss to follow-up and non-consent to linkage.14 
We estimated weighted period prevalence of parent-re-
ported wheezing and GP-recorded asthma diagnoses 
and calculated their difference (parent-reported minus 
GP-recorded) using the prtesti command in STATA. 
We calculated the weighted 12-month period preva-
lence of other respiratory conditions coded by GPs for 
children with parent-reported wheezing and no GP-re-
corded asthma diagnosis. We estimated at each age the 
percentage of children for whom there was agreement 
between parent-reported wheezing and GP-diagnosed 
asthma and calculated Cohen’s kappa statistics. We also 
examined parent-reported asthma medication use for 
children with no reported asthma or wheeze within 
the last 12 months in the MCS. All calculations were 
performed using STATA/SE V.13.0 (Stata Corp, Texas, 
USA) and the R language and environment for statistical 
computing and graphics V.3.3.3 (The R Foundation for 
Statistical Computing, Vienna, Austria).
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resuLts
The prevalence of parent-reported wheezing was highest 
at age 3 years and declined thereafter (table 1). The 
majority of children with parent-reported wheezing expe-
rienced recurrent wheeze in the relevant time period: for 
example, at age 3 years, 27.3%, 49.7% and 23.0% children 
with wheezing in the preceding 12 months were reported 
to have experienced one, between two and four, or five 
or more attacks, respectively, over the same period. The 
majority of children with parent-reported wheezing were 
also reported to have ever had eczema and/or hay fever, 
and this increased with age. At ages 3, 5, 7 and 11 years, 
the weighted percentage (95% CI) of eczema and/or hay 
fever was 58.4 (51.9 to 64.5), 61.8 (54.0 to 69.1), 69.8 
(63.8 to 75.3) and 72.1 (65.2 to 78.1), respectively, among 
those with parent-reported wheezing in the preceding 12 
months.
GP-recorded asthma diagnosis prevalence was lower 
on average than that of parent-reported wheeze and 
declined similarly, although less steeply, with age. The 
difference between these prevalences was greatest at ages 
3 and 5 years and diminished with age such that by 11 
years, differences were no longer significantly different 
(table 1 and figure 1).
At each age, approximately 70% of parents of children 
with GP-recorded asthma diagnoses reported wheezing in 
their child over the same time period (table 2). A higher 
percentage of parents of children with no GP-recorded 
asthma diagnosis reported no wheezing, increasing 
from 83% at age 3 to 94.3% at age 11 years (table 2). 
Overall, agreement between parent-reported wheezing 
and GP-recorded asthma diagnoses increased with age, 
with Cohen’s kappa statistics suggesting moderate to 
substantial agreement by age 7 and 11 years (table 1). 
GP-recorded diagnoses of other respiratory conditions, 
predominantly of the upper respiratory tract, were iden-
tified in almost half of the children with parent-reported 
wheeze but no GP-recorded asthma diagnosis at 3 and 
5 years (45.7% and 44.8%, respectively) and in almost 
one-third at 7 and 11 years (30.2% and 30.1%, respec-
tively) (table 3). Of the parents who reported that their 
child did not have asthma and had not wheezed in the 
last 12 months, none reported regular use of asthma 
medications at ages 5 or 7 years, with only two reporting 
use at age 11 years.
dIscussIon
We found that both parent-reported wheezing and GP-re-
corded asthma diagnoses were more prevalent in the 
preschool years, with wheezing being significantly more 
prevalent than asthma diagnoses at these ages. By primary 
school age, there was moderate to substantial with-
in-child agreement between the two measures. Parents 
of more than two-thirds of children with GP-recorded 
asthma diagnoses reported that their child wheezed in 
the preceding 12 months, and this percentage did not 
vary with age. Most parents of children without a GP-re-
corded asthma diagnosis reported that their child did 
not wheeze, and this percentage increased with age.
Our findings suggest that, at a population level, 
parent-reported wheezing prevalence is greater than 
Table 1 Weighted period prevalence (%), absolute difference and agreement between parent-reported wheezing and GP-
diagnosed asthma in 12 months preceding each cohort interview
Target age for 
interview
(years) n
(n girls; w%*)
Child age at 
interview
(years)
Median (IQR)
Period 
prevalence 
of parent-
reported 
wheezing
% (95% CI)
(A)
Period 
prevalence of 
GP-recorded 
asthma 
diagnosis
% (95% CI)
(B)
Absolute 
difference 
between 
parent-
reported 
wheezing and 
GP-recorded 
asthma 
diagnosis†
% (95% CI)
(A–B)
Agreement 
(%) between 
parent-
reported 
wheezing and 
GP-recorded 
asthma 
diagnosis
% (95% CI)
Cohen’s kappa
(95% CI)
Three years n=1280
(607; 46.0%)
3.1
(3.0 to 3.1)
24.1
(20.6 to 28.0)
13.4
(11.3 to 15.8)
10.7
(7.7 to 13.7)
80.8
(78.6 to 83.0)
0.39
(0.33 to 0.45)
Five years n=1347
(645; 46.5%)
5.3
(5.1 to 5.5)
18.9
(16.7 to 21.3)
13.5
(11.3 to 16.0)
5.4
(2.6 to 8.1)
85.8
(84.0 to 87.7)
0.50
(0.43 to 0.55)
Seven years n=1426
(685; 46.5%)
7.3
(7.1 to 7.5)
13.1
(11.0 to 15.5)
10.4
(8.6 to 12.6)
2.7
(0.3 to 5.1)
91.0
(89.5 to 92.4)
0.57
(0.50 to 0.63)
Eleven years n=1211
(573; 45.9%)
11.2
(11.0 to 11.5)
12.9
(10.6 to 15.4)
10.9
(8.8 to 13.3)
2.0
(−0.5 to 4.5)
91.8
(90.3 to 93.4)
0.61
(0.54 to 0.68)
*w%, weighted percentage.
†CI calculated using prtesti command in STATA on weighted prevalences. Similar estimates derived using McNemar’s test on unweighted 
prevalences (data not shown).
GP, general practitioner.
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GP-recorded asthma diagnosis prevalence in the 
preschool years, with smaller differences remaining in 
primary school-aged children. Differences in estimates 
of prevalence based on these two measures may arise for 
a number of reasons: parents may not take their child 
to the GP for wheezing, the GP may record a different 
diagnosis, or may not record any diagnosis, or parents 
may report other breath sounds as wheeze. Making a 
diagnosis of asthma in preschool-aged children who are 
generally unable to perform spirometry may be difficult. 
We found that other respiratory diagnoses, predomi-
nantly upper respiratory, were recorded in almost half 
of the preschool-aged children for whom there was no 
GP-recorded asthma diagnosis, lending some support 
for the second and fourth of these explanations. We 
also observed consistency between parental report of no 
wheezing and lack of parental-reported asthma medica-
tion use. Across all ages, around 30% of parents with a 
GP-recorded asthma diagnosis did not report wheezing in 
their child over the same 12-month period. While ISAAC 
questions selected a 12-month period for reporting to 
minimise recall bias, the possibility of such bias remains. 
Alternatively, asthma may be well controlled in some chil-
dren with GP-recorded asthma diagnoses who may not 
have experienced any wheezing attacks, or children may 
have experienced symptoms other than wheeze, such as 
cough.
Figure 1 Weighted period prevalence of parent-reported wheezing and GP-recorded asthma diagnoses at specified 
ages. GP, general practitioner.
Table 2 Parent-reported wheezing in 12 months preceding 
cohort interview compared with GP-recorded asthma 
diagnosis over same period by age
Parent-
reported 
wheezing at 
interview
GP-recorded asthma 
diagnosis
n (weighted %)
OverallAsthma No asthma
Age 3 years
  Yes 122 (70.4) 194 (17.0) 316 (24.1)
  No 52 (29.6) 912 (83.0) 964 (75.9)
174 (100) 1106 (100) 1280 (100)
Age 5 years
  Yes 127 (69.8) 132 (11.0) 259 (18.9)
  No 59 (30.2) 1029 (89.0) 1088 (81.1)
186 (100) 1161 (100) 1347 (100)
Age 7 years
  Yes 104 (72.4) 85 (6.2) 189 (13.1)
  No 44 (27.7) 1193 (93.8) 1237 (86.9)
148 (100) 1278 (100) 1426 (100)
Age 11 years
  Yes 95 (71.1) 59 (5.7) 154 (12.9)
  No 40 (28.9) 1017 (94.3) 1057 (87.2)
135 (100) 1076 (100) 1211 (100)
GP, general practitioner.
Table 3 Weighted period prevalence (%) of GP-recorded 
other respiratory diagnoses in 12 months preceding 
interview by age at cohort interview for children with parent-
reported wheezing and without GP-recorded asthma 
diagnoses
Age at cohort 
interview
GP-recorded other respiratory 
diagnoses
Cases/total Weighted % (95% CI)
Three years 88/194 45.7 (37.7 to 53.9)
Five years 59/132 44.8 (33.9 to 56.2)
Seven years 25/85 30.2 (21.9 to 39.9)
Eleven years 18/59 30.1 (20.0 to 42.5)
GP, general practitioner.
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This is to our knowledge the first nationally represen-
tative longitudinal study to compare the prevalence of 
GP-recorded asthma diagnoses in EHRs with the preva-
lence of parent-reported wheezing across early childhood. 
In a smaller study using data from the Avon Longitudinal 
Study of Parents and Children, a birth cohort from South 
West England, Cornish et al linked 141 cohort members to 
their GP records and reported 67% agreement between 
ever-reported wheezing in the past 12 months and GP-re-
corded diagnosis of asthma by 9 years of age.15 Canova 
et al examined the GP records of 593 children born to 
mothers recruited in pregnancy to a longitudinal study 
of asthma: agreement between parent-reported symp-
toms or diagnoses and GP-coded diagnoses declined 
with age.16 Belgrave et al found comparable agreement 
between parental and physician ratings of wheeze in a 
regional birth cohort of 1184 children at ages 3, 5 and 
8 years.17 Mukherjee et al reported the age-standardised 
annual prevalence of patient-reported symptoms sugges-
tive of asthma to be 17.1% based on responses to national 
surveys using standardised questionnaires; this was signifi-
cantly higher than the annual age-standardised preva-
lence of clinician-reported-and-diagnosed asthma (5.7%) 
and clinician-reported-diagnosed-and-treated asthma 
estimated from primary care EHRs.10 Direct comparison 
with our findings is not possible as these estimates were 
not based on comparisons of the same populations and 
were not presented for children separately.
To our knowledge, few other studies have examined 
the prevalence of childhood asthma in the UK using 
EHRs. Punekar and Sheikh5 estimated an 18-year period 
prevalence of clinician-diagnosed asthma in children and 
adolescents across the UK to be 22.9% (95% CI 22.3% 
to 23.4%) from practices contributing to the General 
Practice Research Database. In one study from the Neth-
erlands, Pols et al18 estimated the prevalence of child-
hood asthma to be 6.1%, based on the requirement of at 
least two relevant consultations and at least two relevant 
prescriptions in the primary care record. This is closer 
to our estimate, which also included use of primary care-
coded prescription as well as diagnosis.
Our estimate of the prevalence of parent-reported 
wheezing in the MCS 7-year-olds (13.1%) is lower than 
the prevalence of asthma symptoms (20.9%) in the UK 
reported by Asher et al19 in the ISAAC global Phase Three 
study, a cross-sectional questionnaire survey of 193 404 
children aged 6–7 years from 37 countries. Kuehni et al 
reported the cross-sectional 12-month period prevalence 
of parent-reported wheeze in the Leicestershire longitu-
dinal child cohort to be 12.4%, 12.5% and 20.5% at ages 
3, 6 and 11 years, respectively, which is broadly consistent 
with our estimates.20 Arathimos et al analysed sex differ-
ences in parent-reported wheezing in MCS based on the 
ISAAC questionnaire and estimated the cross-sectional 
prevalence of wheeze in all MCS participants to be 14.4% 
in boys and 10% in girls at age 7 years.21
Strengths of our study include the use of a representa-
tive sample of Welsh children, high rates of consent and 
linkage, and adjustment for attrition and non-consent. 
We compared 12-month period prevalence of GP-re-
corded asthma diagnoses and parent-reported wheezing, 
allowing the age-specific relation between these measures 
to be assessed. Consistent and standardised definitions of 
wheezing and asthma diagnoses were employed at each 
age; however, parents were not asked to report clini-
cian-diagnosed asthma and physiological measures of 
airway function were not available in our study.
It is widely acknowledged that asthma is a heteroge-
neous condition and that definitive diagnostic criteria 
for asthma are lacking; hence, we did not consider 
either measure as a gold standard. Validation of diag-
noses recorded and coded within EHRs and the pheno-
typic algorithms used and assessment of their relation 
to existing accepted measures is needed to evaluate esti-
mates of prevalence, causes and outcomes of chronic 
conditions such as childhood asthma based on EHRs.22 23 
Parental understanding and interpretation of the term 
wheeze may impact on estimates of prevalence based 
on parent report.24 25 We found increasing agreement 
between parent-reported wheeze and GP-recorded 
asthma diagnosis with age. Our findings suggest that 
cross-sectional prevalence estimates of GP-recorded 
asthma diagnoses based on coded EHRs are likely to 
be lower than parent-reported estimates of wheeze in 
preschool-aged children. These differences become 
much smaller at later ages. Further research is needed to 
evaluate the implications of these cross-sectional differ-
ences in prevalence estimates among preschool-aged 
children for the characterisation of longitudinal child-
hood asthma phenotypes21 26 27 based on EHRs.
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